TokenPost·
Vicore Pharma Posts Q3 Loss of SEK 0.44 Per Share as Revenue Falls 25%
Net loss widened to SEK 124.3 million, and cash, cash equivalents and short-term investments totaled SEK 772 million at Sept. 30, 2026.
More news
- TokenPostParaguay’s Peña Submits Resignation as Lawmakers Back Impeachment
- TokenPostAnthropic Begins U.S. Beta of Claude Personal Finance Tool
- TokenPostClinton Urges Congress to Question Musk on Whether DOGE Accessed Sensitive Data
- TokenPostDark Defender Sets $1.56 XRP Trigger in New Wave 3 Chart
- TokenPostGoogle Adds Sketch-Based App Building to Gemini’s Canvas Tool
- TokenPostBitcoin Transfer Leads $600.7 Million in Crypto Moves as Outflows Top Inflows